Metraipolis › archive › dc_a9d2df60ac00

Measurable Residual Disease in Adult Acute B-Lymphoblastic Leukemia: Methods, Guidelines, and Emerging Actionability at Ultra-Low-Level — Europe PMC PMID:42122128

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42122128
DOI
10.3390/cancers18091331
License (as archived)
solo-consultazione
Archived
2026-11-03T07:27:57.783Z
SHA-256 of the archived text
d8498d7537261202c7b1b601e187d64d4678fedba153fbfd637ef9461e1da1d9
Stable URL of this page
https://metraipolis.com/documento/dc_a9d2df60ac00

How to cite

Measurable Residual Disease in Adult Acute B-Lymphoblastic Leukemia: Methods, Guidelines, and Emerging Actionability at Ultra-Low-Level — Europe PMC PMID:42122128 — Europe PMC (en), https://europepmc.org/article/MED/42122128 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a9d2df60ac00 (Metraipolis archive dc_a9d2df60ac00, sha256 d8498d7537261202c7b1b601e187d64d4678fedba153fbfd637ef9461e1da1d9)
BibTeX
@misc{dca9d2df60ac00,
  title = {Measurable Residual Disease in Adult Acute B-Lymphoblastic Leukemia: Methods, Guidelines, and Emerging Actionability at Ultra-Low-Level — Europe PMC PMID:42122128},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42122128},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a9d2df60ac00; sha256 d8498d7537261202c7b1b601e187d64d4678fedba153fbfd637ef9461e1da1d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42122128. Agents can read the archived copy with the MCP tool read_document.